Lipid rafts are cholesterol-rich cell signaling platforms, and their physiological role can be explored by cholesterol depletion. To characterize transcriptional changes ongoing after lipid raft disruption in epidermal keratinocytes, a cell type that synthesizes its cholesterol in situ, we performed whole-genome expression profiling. Microarray results show that over 3,000 genes are differentially regulated. In particular, IL-8, urokinaselike plasminogen activator receptor, and metalloproteinases are highly upregulated after cholesterol extraction. Quantitative reverse transcriptase PCR validation and protein release measurements demonstrate the physiological relevance of microarray data. Major enriched terms and functions, determined by Ingenuity Pathways Analysis, identify cholesterol biosynthesis as a major function, illustrating the specificity of keratinocyte response toward cholesterol depletion. Moreover, the inflammatory skin disorder atopic dermatitis (AD) is identified as the disease most closely associated with the profile of lipid raft-disrupted keratinocytes. This finding is confirmed in skin of AD patients, in whom transcript levels of major lipid raft target genes are similarly regulated in lesional atopic skin, compared with non-lesional and normal skin. Thus, lipid raft disruption evokes typical features of AD, thereby suggesting that lipid raft organization and signaling could be perturbed in atopic keratinocytes.
INTRODUCTION
As the existence of membrane lipid rafts is now established (Simons and Toomre, 2000; Foster, 2008) , large-scale functional studies start unraveling the relevance of lipid rafts in cell signaling and physiology (Yaqoob and Shaikh, 2010) . Presently, lipid rafts are defined as dynamic nanoscale membrane microdomains containing high amounts of cholesterol and sphingolipids that, on activation, coalesce into large signaling platforms (Pike, 2006 (Pike, , 2009 . A regulated amount of cholesterol is crucial for all animal plasma membranes, as cholesterol helps in regulating the fluidity of the membrane. Moreover, the presence of membrane cholesterol and lipid raft existence is tightly related to cellular cholesterol biosynthesis (Lange et al., 2004) . In epidermis, cholesterol is also needed for the establishment of the cornified barrier (Wertz and Michniak, 2000) , this tissue being an active site of cholesterol synthesis. Thus, numerous lipid raft aggregates have been found, for instance, in transitamplifying keratinocytes (Gniadecki and Bang, 2003) . Membrane cholesterol depletion by methyl-b-cyclodextrin (MBCD) is known to disrupt lipid rafts in keratinocytes (Kabouridis et al., 2000; Jans et al., 2004) and it has been shown that the signaling molecules p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and epidermal growth factor receptor (EGFR) are activated and that the expression of involucrin (IVL) and keratin 10, two epidermal differentiation markers, is altered after lipid raft disruption (Jans et al., 2004; Lambert et al., 2006; . Parallelisms in response of keratinocytes to cholesterol depletion or to H 2 O 2 suggested an involvement of oxidative mechanisms subsequent to lipid raft perturbation, but a panel of experimental data refuted that hypothesis (Mathay and Poumay, 2010) . To acquire a global view of transcriptional changes occurring after lipid raft perturbation by cholesterol depletion, whole-genome transcriptional profiling in MBCD-treated keratinocytes was performed. This powerful technique combined with bioinformatics data analyses allows the identification and characterization of lipid raft-dependent transcriptional targets and cell signaling & 2010 The Society for Investigative Dermatology www.jidonline.org 1 pathways, as well as association of functions and diseases with lipid raft-disrupted keratinocytes. Atopic dermatitis (AD), a skin disease characterized by allergic skin inflammation and dysfunctional epidermal barrier (Oyoshi et al., 2009) , shows strong parallelisms in expression profiles with lipid raft-disrupted keratinocytes. Skin biopsies of AD patients show that lipid raft disruption identifies critical mediators of certain AD pathways.
RESULTS

Transcriptional response of lipid raft-disrupted keratinocytes
The dynamics of keratinocyte response to lipid raft disruption by MBCD was evaluated by measuring transcript levels immediately after cholesterol depletion (R0h) or after recovery periods of 1 hour (R1h) and 8 hours (R8h). Time points were chosen in accordance with previous studies showing heparin-binding EGF-like growth factor (HB-EGF) gene regulation, together with alterations in epidermal differentiation markers IVL and keratin 10 . Analysis of transcripts encoded by these genes using microarray and real-time PCR and analysis of phosphorylation of EGFR, Akt, and p38 mitogen-activated protein kinase confirm the typical effects observed after cholesterol depletion (Supplementary Figure S1 online). Expression profiling in cholesterol-depleted keratinocytes shows that immediate-early gene response to MBCD is limited to 59 genes at R0h, 392 genes at R1h, but transcriptional changes representing 2,756 differentially regulated genes (DRGs) occur during the 8-hour recovery phase (Supplementary Figure S1 online). Conversely, mock cholesterol depletion by MBCD/cholesterol complexes induces a small number of DRGs only. Thus, for the clarity of data presentation, comparisons between MBCD versus control are solely illustrated. Complete lists of DRGs for keratinocytes treated with MBCD or cholesterolloaded MBCD compared with controls are provided in Supplementary Figure S2 online. Reflecting the biological relevance of gene regulation, DRGs were classified according to comparison fold changes as recommended by Shi et al. (2008) . In Table 1 , the 20 highest fold changes (up-and downregulation) for the comparison between MBCD versus control are shown for each recovery period. HB-EGF is identified among the major transcriptional targets at R0h and R1h after MBCD treatment. Similarly, IL genes are highly responsive toward membrane cholesterol depletion, with ILs IL-8, IL-1B, and IL-20, or Interleukin receptors IL-13RA2, IL-1RL1, and IL-1R2, being highly induced, especially at R8h. Most notably, proinflammatory cytokine IL-8 is identified as the most highly induced gene at R1h, and is also highly induced at R8h. Other genes involved in the inflammatory response, including prostaglandin-endoperoxide synthase 2 (PTGS2; cyclooxygenase (COX-2)), plasminogen activator, urokinase receptor (PLAUR), and the metalloproteinases (MMP1 and MMP10), are also highly induced. However potential inflammatory responses seem tightly regulated as the suppressor of cytokine signaling 3(SOCS3) and IL-1RL1, which functions as an anti-inflammatory receptor (Brint et al., 2004) , are also highly expressed after cholesterol depletion. Interestingly, members of the epidermal differentiation complex, filaggrin (FLG), FLG-2 (a recently identified member of the epidermal differentiation complex; Wu et al., 2009) , and cornifelin, are strongly downregulated immediately after MBCD treatment. Furthermore, several zinc-finger transcription factors (ZNF434, ZNF57, ZNF14) are downregulated at R1h.
Real-time PCR validation of major MBCD-transcriptional targets
Transcript levels of several microarray-identified DRGs were investigated by quantitative real-time PCR to ensure the accuracy of genome expression profiling (Table 2) . Gene selection was based on their biological importance in epidermal keratinocytes and on their differential expression in at least two analyzed time points. When comparing both techniques, expression values of all eight analyzed genes indicate regulations with same directions and levels, thus exhibiting very similar profiles. Indeed, cholesterol depletion significantly induces activating transcription factor 3 (ATF3) at R1h, and high expression levels of HB-EGF and IL-8 are confirmed for all three time points. When analyzed during an 18-hour time-course experiment, the highest IL-8 gene expression level occurs 2 hours after cholesterol depletion (Supplementary Figure S3 online ). INSIG1, a gene involved in cellular cholesterol homeostasis, exhibits significantly increased mRNA expression at R1h and R8h after cholesterol depletion (Table 2) , indicating cell reaction toward cholesterol synthesis. Expression of matrix metalloproteinase (MMP)1 and MMP10, key regulators of epidermal remodeling during wound healing, is also significantly increased during the delayed recovery phase (R8h; Table 2), with maximal induction of MMP10 at R4h (Supplementary Figure S3 online). Interestingly, expression profiling of AD patients' keratinocytes has also identified MMP1 and MMP10 as major transcriptional targets (Lu et al., 2009) . Transcript levels of the urokinase-like plasminogen activator receptor (uPAR or PLAUR) are highly elevated at R1h and R8h (Table 2) . Maximal PLAUR induction occurs 2 hours after MBCD treatment (Supplementary Figure S3 online) . Our data are in accordance with a recent study of vascular smooth muscle cells showing that cholesterol depletion also increases PLAUR mRNA levels (Kiyan et al., 2009 ). Significant increases in PTGS2 (COX-2) expression, a pivotal factor in inflammatory processes, are detected at R1h, R2h, R4h, and R8h after cholesterol extraction (Supplementary Figure S3  online and Table 2 ).
Analysis of IL-8, PLAU, and PLAUR protein expression
The protein relevance of IL-8 gene induction after cholesterol depletion by MBCD was investigated by measurement of IL-8 release by keratinocytes (Figure 1a ). Compared with control and cholesterol-loaded MBCD-treated cells, cholesteroldepleted keratinocytes secrete significant amounts of IL-8 as early as 2 hours after cholesterol depletion (R2h), reaching maximal levels at late recovery times (R8h and R18h). The urokinase receptor system was more completely explored as PLAUR is localized in lipid rafts (Sitrin et al., 2004) and as PLAU (the expression of which is also augmented in case of Figure S2 online) binding to its receptor stimulates cholesterol synthesis (Fuhrman et al., 2007) . Highly significant extracellular PLAU release actually occurs between R4h and R8h after the initial cholesterol depletion (Figure 1b ). This time schedule exactly corresponds to the recovery period during which the PLAUR protein expression is induced in keratinocytes (Figure 1c ), suggesting potential ligand-induced PLAUR activation during this period.
Network and pathway exploration of DRG after membrane cholesterol depletion
To identify potential regulatory networks and pathways from microarray data, lists of DRG after MBCD treatment were uploaded into the bioinformatics tool Ingenuity Pathways Analysis (IPA). IPA's capacity of discriminating relevant functions, pathways, and networks was checked with random gene lists. In reality, IPA analysis reveals that ''cholesterol biosynthesis'' and ''hormone receptor-regulated cholesterol Abbreviations: ATP, adenosine-5'-triphosphate; EGF, epidermal growth factor; GTP, green florescent protein; R0h, cholesterol depletion at 0 hours; R1h, at 1 hour; R8h, at 8 hours.
Shown are the 20 most highly up-and downregulated genes classified according to their fold change (for all genes: adjusted P-values o0.05).
metabolism'' are major cellular processes associated with DRG 8 hours after cholesterol depletion ( Figure 2a ). The gene ontology term ''cholesterol biosynthesis'' contains a set of 16 involved genes, of which 10 are DRGs in the R8h data set ( Figure 2b ). Among these are key enzymes of cholesterol synthesis, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, 3-hydroxy-3-methyl-glutaryl-coenzyme A synthase 1, 7-dehydrocholesterol reductase, and squalene epoxidase, which are all highly upregulated in these conditions. Thus, keratinocytes respond to cholesterol depletion by inducing Figure 1 . PLAUR expression, and PLAU and IL-8 release after cholesterol depletion. Functional time-course analysis shows that MBCD induces PLAUR protein expression, as well as PLAU and IL-8 protein release. (a) Extracellular IL-8 release subsequent to MBCD and MBCD/chol treatments (means ± SEM; n ¼ 4). (b) Extracellular PLAU release subsequent to MBCD and MBCD/chol treatments (means±SEM; n ¼ 3). (c) Western blot analysis of PLAUR protein expression in cell lysates of cholesterol-depleted keratinocytes (representative data obtained from three independent experiments). chol, cholesterol; Crtl, control, MBCD, methyl-b-cyclodextrin; PLAU, plasminogen activator urokinase; PLAUR, plasminogen activator urokinase receptor; R0h, cholesterol depletion at 0 hours; R1h, at 1 hour; R2h, at 2 hours; R4h, at 4 hours, R18h, at 18 hours. *Po0.05; **Po0.01; Dunnett's test.
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produced from cholesterol and that cholesterol depletion perturbs endocrine steroid regulatory mechanisms.
Potential networks for cholesterol-depleted keratinocytes generate previously unreported working hypotheses and identify critical mediators of AD pathways At R0h after cholesterol depletion, a potential network involving TGFB1, IL-6, and IL-8 is suggested by IPA analysis. The presence of PTGS2, activating transcription factor 3, and PLAUR in this network is remarkable (Figure 3a) . Thereafter, a second network centered on tumor necrosis factor-a is top-scored at time point R1h (Figure 3b ), featuring HB-EGF, IL-8, PTGS2, and MMP1 as possibly tumor necrosis factor-a-regulated genes in cholesterol-depleted keratinocytes. Interestingly, ''dermatological diseases and conditions'' and ''inflammatory disease'' are key terms associated with this network.
Finally, at time point R8h, the inflammatory network prevails, featuring ILs-1a and -b as central factors. In this network, MMP1, 3, and 9, as well as PTGS2 and IL-8, have very important roles (Figure 3c) .
Functional annotation analysis of DRGs revealed that ''dermatological diseases and conditions'' was a function strongly associated with R0h and R1h data sets, a highly interesting result as standard IPA settings were used. Therefore, we investigated which dermatological disease associates best. AD associates the most significantly with the transcriptional profile observed at R0h, and AD is second at R1h after lipid raft disruption by MBCD (Supplementary Figure S5 online) . Intersection of MBCD-regulated genes and genes related to AD include IL-8, PTGS2, IL-1RN, SOCS3, DUSP1, DUSP2, DUSP5, and transcription factors JUN, JUNB, and ZFP36 (all of which are upregulated) and the only downregulated epidermal gene FLG (Supplementary Figure S5 online www.jidonline.org 7
Having identified a potential relationship between cholesterol depletion and AD, links between dermatitis and the top-scored networks were found, and highlighted in blue in Figure 3 . Each of the networks illustrates at least five genes involved in the disease, suggesting that cholesterol depletion could mimic certain features of AD.
Transcript levels of cholesterol-regulated genes that are members of the epidermal differentiation cluster are shown in Figure 4a . To test whether cholesterol depletion has crucial effects on genes that are deregulated in AD, skin biopsy specimens of acute lesions and surrounding normal-appearing skin of AD patients (average age: 39 years), as well as biopsy specimens of healthy volunteers (average age: 43 years), were collected after informed consent. When performing comparisons between groups of AD patients and healthy persons, no age-related effects were observed. Using real-time PCR, transcript levels of several major targets of cholesterol depletion were analyzed (Figure 4b-h) . The mean expression of late differentiation markers FLG and loricrin (LOR) is approximately twofold significantly decreased in AD skin (either lesional or non-lesional) when compared with healthy skin (Figure 4b and c) . Inside or outside AD lesions, no difference in the expression of these two genes could be detected. IVL and transglutaminase (TGM-1) exhibit similar mRNA levels in both healthy and non-lesional AD skin, whereas expression of these two genes is increased for every patient, leading to a significant mean increase in IVL and TGM-1 in lesional compared with non-lesional AD skin (Figure 4d and e) . In healthy patients, the expression level of HB-EGF presents a high variability, especially in two samples, probably as a consequence of the collecting procedure, HB-EGF being an early stress-responsive gene . In samples from AD patients, the nonlesional HB-EGF expression level is low but increases significantly in lesional areas of most AD patients ( Figure  4f ). Similarly, IL-8 transcript levels exhibit particularly high values in lesional AD skin, compared with either non-lesional areas or healthy samples (Figure 4g ), revealing the important inflammatory response in acute AD lesions. Regarding PLAUR expression levels, no tendency in expression can be detected between healthy and non-lesional AD skin; however, each AD patient reveals an increase in PLAUR transcript levels in lesions compared with levels in non-lesional areas (Figure 4h ) and the average PLAUR expression is significantly increased in lesional AD skin. Thus, elevated IL-8, PLAUR, HB-EGF, and TGM1 expression can be considered as a previously unreported gene signature of inflammatory lesional AD plaques. 
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In summary, when comparing AD skin with normal skin, increased expression levels of IVL, TGM1, HB-EGF, IL-8, and PLAUR are detected simultaneously with a decreased expression of FLG and LOR. These observations are in good concordance with transcriptional analysis of gene expression in lipid raft-disrupted keratinocytes, strongly suggesting that membrane organization and signaling might be disturbed in AD keratinocytes.
DISCUSSION
Genome expression profiling in cholesterol-depleted keratinocytes reveals hundreds of DRGs as an immediate or later consequence of lipid raft disruption. Such a strong transcriptional regulation may likely be explained by the fact that lipid rafts are known to host large numbers of signaling molecules that cannot form competent signaling assemblies after cholesterol extraction. Data presented here illustrate that processes initiated by cholesterol depletion are complex and dynamic, involving IL-8, HB-EGF, and PLAUR, for instance, among major transcriptional targets, an observation confirmed by protein analysis and showing the physiological importance of cholesterol-dependent gene expression in keratinocytes.
IL-8 and PLAU induction and secretion, together with HB-EGF release (Giltaire and Poumay, unpublished results), as a consequence of lipid raft disruption are to our best knowledge previously unreported results. IL-8 is an inflammatory marker induced by various stress signals and recently EGFRdependent IL-8 synthesis has been shown in wounded keratinocytes, a process that contributes to injury-initiated neutrophil recruitment (Roupé et al., 2010) .
Highly elevated PLAUR transcript levels are also detected after cholesterol depletion (Figure 1 ). The urokinase system PLAU/PLAUR is mainly known for its fibrinolytic function during tissue remodeling; however, PLAUR is also involved in cell adhesion, migration, and signaling (Ragno, 2006; Caceres et al., 2008) . Further investigations of this urokinase system represent promising areas of research because cholesterol biosynthesis is increased not only by PLAU binding to its receptor (Fuhrman et al., 2007) but also because PLAU secretion and increased PLAUR expression are induced as a response to cholesterol depletion. Thus, the PLAU/PLAUR system may be suspected to enhance cholesterol biosynthesis. Moreover, PLAU binding to its receptor increases the lipid raft affinity of this GPI-anchored receptor (Sahores et al., 2008) . In prostate cells, PLAU is able to stimulate autocrine HB-EGF production, thereby maintaining EGFR activation (Caceres et al., 2008) . A similar mechanism might function in keratinocytes after cholesterol depletion as PLAU secretion is observed (Figure 1b) and HB-EGF is simultaneously released (Giltaire and Poumay, in preparation). Furthermore, it has been shown that, in keratinocytes, EGFR activation depends on PLAUR membrane expression (D'Alessio et al., 2008) . EGFR is activated immediately after cholesterol depletion (Jans et al., 2004; Lambert et al., 2008) , probably because the required basal PLAUR levels are present, but PLAUR levels are also highly increased during the recovery period after cholesterol depletion. Finally, our data concur with a study conducted on vascular smooth muscle cells showing PLAUR induction following cholesterol depletion (Kiyan et al., 2009) .
In our present data, gene ontology analysis of DRG after cholesterol depletion in keratinocytes has pointed out AD as the dermatological disease that best fits the gene regulation obtained by cholesterol depletion. Thus, we tested whether major genes regulated after lipid rafts disruption by cholesterol depletion could similarly be regulated in AD skin biopsies. Indeed, data revealed good concordance between AD and lipid raft disruption.
Since the discovery of an increased risk of AD in patients carrying FLG mutations (Palmer et al., 2006) , the involvement of epidermal differentiation cluster genes in etiopathology of AD has drawn considerable scientific interest. In AD skin, a decreased expression of FLG is generally observed (Sugiura et al., 2005; Guttman-Yassky et al., 2009) and might contribute to the impaired epidermal barrier of acute AD lesions. Our data also illustrate significantly decreased FLG and LOR expression in AD, together with increased IVL, perfectly matching literature data (Sugiura et al., 2005; Howell et al., 2007; Jarzab et al., 2010) , as well as data observed in cholesterol-depleted keratinocytes. Thus, three members of the epidermal differentiation cluster are similarly regulated in AD and in keratinocytes with disrupted lipid rafts. In addition, an interesting increase in SOCS3 expression and PLAUR activity is detected in AD (Saaf et al., 2008; Voegeli et al., 2009) , similar to that in cholesterol-depleted keratinocytes. Finally, although individual gene expression variations occur, no particular age-related effect could be identified between cohorts of patients.
Intriguing parallelisms in our data strongly suggest that keratinocyte lipid rafts could be involved in the etiopathology of AD, maybe by impaired lipid raft organization or perturbed signaling in AD. Interestingly, during the process of epidermal barrier maturation, lamellar bodies exhibit properties of lipid rafts (Menon, 2003) ; indeed lamellar bodies are enriched in caveolin-1, a lipid raft marker protein (Sando et al., 2003) , and the fusion of lamellar bodies with the apical plasma membrane of granular keratinocytes is regulated by membrane cholesterol (Roelandt et al., 2009) . Thus, as a correct exocytosis of lamellar bodies is required for the function of the epidermal barrier, and as lamellar body formation and delivery mechanisms are perturbed in AD, leading to an impaired epidermal barrier (Fartasch et al., 1992) , the functioning of keratinocyte lipid rafts could be compromised in AD. Moreover, a profiling study in AD patients has recently revealed a marked differential regulation of genes involved in lipid biosynthesis (Saaf et al., 2008) , genes that are also regulated after lipid raft disruption (Figure 2 ). These data provide additional support for the hypothetical involvement of lipid rafts in AD. Finally, data from recent literature demonstrate that miltefosine, an alkylphospholipid with high affinity for lipid rafts (Barratt et al., 2009) Bäumer et al., 2010; Dö lle et al., 2010) , bringing an additional argument for our hypothesis. Altogether, this study first contributes to a better knowledge of epidermal lipid rafts and their associated signaling, as it demonstrates their physiological relevance in keratinocytes in inducing IL-8, PLAU, and PLAUR, in addition to HB-EGF. Second, the detailed analysis of signaling pathways perturbed by lipid raft disruption has identified crucial mediators involved in the etiopathology of AD.
MATERIALS AND METHODS
Chemicals and culture media MBCD and cholesterol were obtained from Sigma-Aldrich (Bornem, Belgium). Keratinocyte growth medium 2 was purchased from Clonetics (Lonza, Verviers, Belgium). Keratinocyte complete culture medium (Epilife with human keratinocyte growth supplement) and keratinocyte autocrine culture medium (Epilife without human keratinocyte growth supplement) were from Cascade Biologics (Invitrogen, Merelbeke, Belgium).
Skin biopsies and culture of human normal epidermal keratinocytes
This study was conducted in accordance with the Declaration of Helsinki. The study was approved by the Ethics Committee of the University Hospital Center of Liège and by the medical ethical committee of Clinique St Luc, Namur. The whole procedure of the study was fully explained to all volunteers who gave their written informed consent. None of the AD patients were receiving any topical or systemic therapy other than hydrating creams. Supplementary Table S2 online summarizes demographic data of seven AD volunteers suffering from longstanding AD who underwent a skin biopsy on lesional and surrounding non-lesional skin and of eight healthy volunteers. Superficial 2 mm punch biopsies, composed of mainly epidermis with minimal dermis amounts, were taken from AD patients under local anesthesia and then stored in RNAlater (Qiagen, Venlo, The Netherlands) before RNA extraction (RNeasy Micro, Qiagen) and real-time PCR analysis. For healthy samples and in vitro culture experiments, abdominal or breast skin samples obtained from plastic surgery were used and keratinocyte cultures were grown in autocrine culture medium until confluence as described earlier (Minner et al., 2010) .
Lipid raft disruption by cholesterol depletion
Cholesterol depletion in confluent keratinocyte cultures was performed by 7.5 mM (1% wt/vol) MBCD for 1 hour. For mock cholesterol depletion (negative control), cells were incubated for 1 hour with 7.5 mM cholesterol-loaded MBCD complexes (cholesterol-loaded MBCD; Klein et al., 1995) . Cells were harvested either immediately after MBCD treatment (R0h) or were allowed to recover in autocrine culture medium for 1 hour (R1h) or 8 hours (R8h).
Microarray and bioinformatics analyses
Detailed microarray and bioinformatics analyses are described in Supplementary Methods online. Briefly, tRNA integrity was analyzed (Agilent 2100 Bioanalyzer; Agilent, Santa Rosa, CA) and wholegenome expression levels were determined on Affymetrix HG-U133 Plus 2.0 GeneChips (Affymetrix, Sunnyvale, CA). Probe sets with a fold change 42 or oÀ2 and a P-value lower than 0.05 were defined to be differentially regulated and were selected for further analyses. In compliance with minimum information about a microarray experiment standards, data files were deposited into the NCBI Gene Expression Omnibus. The Gene Expression Omnibus accession number is GSE21364. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21364.
Network generation and functional analysis of microarray data
Lists of DRGs with associated fold changes and P-values were imported into the Ingenuity Pathway Analysis 7.5 tool (Ingenuity Systems, Redwood City, CA). The basis of the IPA tool consists of the Ingenuity Pathway Knowledge Base, which is derived from known functions and published gene interactions. The most relevant biological networks, functions, or pathways of a data set were identified by a Fischer's exact test computing a P-value that determines the probability that the network, function, or pathway assigned to that data set is because of chance alone.
Real-time PCR protocol and primer sequences (Supplementary Table S1 online) are available in online Supplementary Methods online.
Protein extraction and western blotting
Immediately after the indicated treatments, cells were washed with phosphate-buffered saline and harvested in twice-concentrated Laemmli sample buffer without dithiothreitol (62.5 mM Tris-HCl, 2% SDS, 8.7% glycerol, 0.05% bromophenol blue). Proteins were analyzed by SDS-PAGE and by blotting onto polyvinylidene fluoride membranes (GE Healthcare Bio-Sciences, Uppsala, Sweden). Blocking of the membrane was followed by incubation with primary antibodies against PLAUR (R&D Systems, Abigdon, UK) and b-actin (Sigma-Aldrich, Bornem, Belgium), followed by incubation with secondary antibodies. Chemoluminescent detection was carried out as described previously .
IL-8/PLAU measurement
IL-8 and PLAU protein concentrations were measured in cell culture medium using commercial quantitative sandwich immunoassays (Duoset, R&D systems, Abigdon, UK). Each sample was assayed in duplicate according to the manufacturer's instructions, and detection was carried out at 450 nm (wavelength correction: 540 nm) in a microplate reader (VersaMax Molecular Devices, Sunnyvale, CA). IL-8 and PLAU concentrations were calculated following standard curves. Figure S1 : Confirmation of known cholesterol-depletion induced effects on cell signalling molecules and mRNA expression of selected genes Figure S1 : Confirmation of known cholesterol-depletion induced effects on cell signalling molecules and mRNA expression of selected genes. a. Western blot analysis of proteins extracted immediately after treatment (R0h) from untreated confluent keratinocytes cultures, cholesterol-depleted keratinocytes (7.5 mM MBCD for 1h) or mock cholesterol-depleted keratinocytes (7.5 mM MBCD/chol for 1h). b. mRNA expression analysis of HB-EGF, the early differentiation marker keratin 10 (KRT10) and the late differentiation markers involucrin and transglutaminase-1 (TGM1) in untreated keratinocytes (Ctrl), in 7.5mM MBCD-treated keratinocytes and in 7.5mM MBCD/chol-treated keratinocytes, immediately after the treatment (R0h) or after 1h or 8h recovery (R1h respectively R8h), by microarray technique and real-time PCR (3 independent experiments). Differential gene regulations are indicated in gray.
Microarray analysis
The integrity of tRNA samples was analysed (Agilent 2100 Bioanalyser) and whole genome expression measurements were performed on Affymetrix HG-U133 Plus 2.0 GeneChips®. Nine arrays were used for the three conditions (Ctrl, MBCD and MBCD/chol) tested at each of the three time points (R0h, R1h and R8h). Microarray analysis was conducted according to manufacturer's instructions for the Affymetrix One Cycle Target Labeling and Control Reagents kit (Santa Clara, CA). Briefly, cDNA was generated from 1.5 µg of total RNA using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA) and T7 Oligo(dT) primer. Subsequently, the products were column-purified (Affymetrix) and then in vitro transcribed to generate biotinlabeled cRNA. The IVT products were then column-purified, fragmented, and hybridized onto Affymetrix U133 Plus 2.0 GeneChips® at 45º C for 16 h. Subsequent to hybridization, the arrays were washed and stained with a b streptavidin-phycoerythrin, then scanned in an Affymetrix GeneChip® Scanner 3000 (Santa Clara, CA). All control parameters were confirmed to be within normal ranges before normalization and data reduction was initiated. CEL files were obtained and an alternative CDF from AffyProbeMiner (Liu et al., 2007) was used to link digitalized signals to gene names. AffyProbeMiner assigns the 1.400.000 probes of HG-U133 Plus 2.0 to 23.800 probe sets representing the whole human genome. The CDF used is « transcript-consistent », so each probe of a probe set maps to the same set of transcripts. The minimal size of a probe set was set to five probes (Liu et al., 2007) . Gene annotation by AffyProbeMiner resulted for some genes in the fact that multiple probe sets correspond to one gene. Pre-processing was performed with GCRMA (Wu et al., 2004) with default parameters. For each probe set, fold changes (ratio of expression between two conditions) (Draghici, 2002) were calculated for six comparisons (for each time point MBCD versus Ctrl and MBCD/chol versus Ctrl). ANOVA 2 with conditions and probes as levels (Barrera et al., 2004) was performed to measure the statistical significance of differential expression for each probe set in the six comparisons. P values were adjusted for multiple testing using False Discovery Rate analysis (Benjamini and Hochberg, 1995) . Probe sets with a fold change higher than 2 or lower than -2 and a p-value lower than 0.05 were defined to be differentially regulated and were selected for further analyses. The entire analysis was made with the R statistical software (Ihaka and Gentleman, 1996) and packages from Bioconductor . In compliance with MIAME standards, data files were deposited into the NCBI Gene Expression Omnibus (GEO). The following link was created to allow review of these data: The GEO accession number is GSE21364. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21364
Real-time PCR
RNA extraction (RNeasy, Qiagen, Hilden, Germany), reverse transcription (Super Script II RNase H (Invitrogen, Merelbeke, Belgium) and real-time PCR were done as described by with primer sequences listed in Table S1 . Each reaction (40 cycles comprising each 15 seconds at 95°C and 1 min at 60°C) was performed using Power SYBR Green PCR Master Mix (Applied Biosystems) in a 7300 real-time PCR machine (Applied Biosystems, Lennik, Belgium). The specificity of the PCR products was verified by melting curves. TBP and RPLP0 had previously been selected for gene expression normalization by GeNorm analysis and relative gene expression was calculated as described by Minner and Poumay (2009) . Fold changes were calculated for the six comparisons: MBCD versus Ctrl and MBCD/chol versus Ctrl for each of the three time points. ACCTCTGCCACCGGATGTC  GTCGCCTCTTTTTCCTTTCATCT  HBEGF  TGGCCCTCCACTCCTCATC  GGGTCACAGAACCATCCTAGCT  FLG  GGGCACTGAAAGGCAAAAAG  CACCATAATCATAATCTGCACTACCA  IL8  GCAGAGGGTTGTGGAGAAGTTT  TTGGATACCACAGAGAATGAATTTTT  INSIG1  CTCTTCCCCGAGGAGGTGAT  TCCGAGGTGACTGTCGATACAG  IVL  TGAAACAGCCAACTCCAC  TTCCTCTTGCTTTGATGGG  LOR  TCATGATGCTACCCGAGGTTTG  CAGAACTAGATGCAGCCGGAGA  MMP1  AGCTAGCTCAGGATGACATTGATG  GCCGATGGGCTGGACAG  MMP10  TTCCAGGAGTTGAGCCTAAGGT  AAACTGTGATGATCCACTGAAGAAGT  PLAUR  GACCTCTGCAGGACCACGAT  CGATAGCTCAGGGTCCTGTTG  PTGS2  CCTTCCTCCTGTGCCTGATG  ACAATCTCATTTGAATCAGGAAGCT  RPLP0  ATCAACGGGTACAAACGAGTC  CAGATGGATCAGCCAAGAAGG  TBP  TCAAACCCAGAATTGTTCTCCTTAT  CCTGAATCCCTTTAGAATAGGGTAGA  TGM1 GTCGTCTTCCGGCTCGAA TCACTGTTTCATTGCCTCCAAT Figure S2 is an Excel file (GSE21364_fold_change_data.xls.gz) which is available online on GEO: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21364 Figure S2 : Differentially up-and down-regulated genes in MBCD-respectively MBCD/chol treated confluent keratinocyte cultures analysed immediately after treatment (R0h) or after 1h respectively 8h of recovery (R1h respectively R8h). Figure S4 : Comparison analysis of the nine most significant biological functions assigned to differentially regulated genes for time points R0h (a), R1h (b) and R8h (c). Biological functions include the three subheadings: diseases and disorders, molecular and cellular functions, physiological system development and function. Significance (-log (p-value) ) is indicated by the height of the bars. The x-axis crosses the y-axis at the 1.3 threshold of significance (-log (p=0.05)=1.3) (IPA 7.5). Figure S5 : Illustration of the highest represented functional groups of the category "Dermatological Diseases and Conditions" and description of the transcriptional regulation of the involved genes. Upregulated genes are indicated in normal characters, downregulated genes are in bold and italic characters. Data were analysed by IPA 7.5.
